Literature DB >> 15714521

Role of beta-galactosidase and elastin binding protein in lysosomal and nonlysosomal complexes of patients with GM1-gangliosidosis.

Anna Caciotti1, Maria Alice Donati, Avihu Boneh, Alessandra d'Azzo, Antonio Federico, Rossella Parini, Danielas Antuzzi, Tiziana Bardelli, Daniele Nosi, Virginia Kimonis, Enrico Zammarchi, Amelia Morrone.   

Abstract

G(M1)-gangliosidosis is a lysosomal storage disorder caused by a deficiency of beta-galactosidase (GLB1). The GLB1 gene gives rise to the GLB1 lysosomal enzyme and to the elastin binding protein (EBP), involved in elastic fiber deposition. GLB1 forms a complex with protective protein cathepsin A (PPCA), alpha neuraminidase (NEU1), and galactosamine 6-sulphate sulfatase (GALNS) inside lysosomes, while EBP binds to PPCA and NEU1 on the cell surface. We investigated the function of the GLB1 and EBP mutated proteins by analyzing the clinical, genetic, and cellular data of 11 G(M1)-gangliosidosis patients. Their molecular analysis, followed by expression studies, lead to the identification of four new and 10 known GLB1 mutations. Some common amino acid substitutions [c.1445G>A (p.Arg482H), c.622C>T (p.Arg208His), c.175C>T (p.Arg59Cys) and c.176G>A (p.Arg59His)] were present in the GLB1 enzyme of several patients, all of Mediterranean origin, suggesting a common origin. Western blotting analyses against GLB1, EBP, and PPCA proteins showed that the identified mutations affect GLB1 enzyme activity and/or stability. The c.1445G>A (p.Arg482His), c.175C>T (p.Arg59Cys), c.733+2T>C, c.1736G>A (p.Gly579Asp), and c.1051C>T (p.Arg351X) GLB1 mutations, affect the stabilization of PPCA probably because they hamper the interaction between GLB1/EBP and PPCA within the multiprotein complex. The amount of EBP was normal, but the detection of impaired elastogenesis in such patients suggests an alteration in its function. We conclude that the presence of genetic lesions in both GLB1 and EBP coding region does not directly predict impaired elastogenesis and that elastic fiber assembly has to be evaluated specifically in each case. Nevertheless, the degree of EBP involvement may be linked to specific clinical findings. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15714521     DOI: 10.1002/humu.20147

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  17 in total

Review 1.  The GM1 and GM2 Gangliosidoses: Natural History and Progress toward Therapy.

Authors:  Debra S Regier; Richard L Proia; Alessandra D'Azzo; Cynthia J Tifft
Journal:  Pediatr Endocrinol Rev       Date:  2016-06

2.  Sustained normalization of neurological disease after intracranial gene therapy in a feline model.

Authors:  Victoria J McCurdy; Aime K Johnson; Heather L Gray-Edwards; Ashley N Randle; Brandon L Brunson; Nancy E Morrison; Nouha Salibi; Jacob A Johnson; Misako Hwang; Ronald J Beyers; Stanley G Leroy; Stacy Maitland; Thomas S Denney; Nancy R Cox; Henry J Baker; Miguel Sena-Esteves; Douglas R Martin
Journal:  Sci Transl Med       Date:  2014-04-09       Impact factor: 17.956

3.  Primary and secondary elastin-binding protein defect leads to impaired elastogenesis in fibroblasts from GM1-gangliosidosis patients.

Authors:  Anna Caciotti; Maria Alice Donati; Tiziana Bardelli; Alessandra d'Azzo; Graziella Massai; Luciana Luciani; Enrico Zammarchi; Amelia Morrone
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

4.  Three novel beta-galactosidase gene mutations in Han Chinese patients with GM1 gangliosidosis are correlated with disease severity.

Authors:  Chi-Fan Yang; Jer-Yuarn Wu; Fuu-Jen Tsai
Journal:  J Biomed Sci       Date:  2010-09-30       Impact factor: 8.410

5.  Molecular consequences of the pathogenic mutation in feline GM1 gangliosidosis.

Authors:  Douglas R Martin; Brigitte A Rigat; Polly Foureman; G S Varadarajan; Misako Hwang; Barbara K Krum; Bruce F Smith; John W Callahan; Don J Mahuran; Henry J Baker
Journal:  Mol Genet Metab       Date:  2008-03-18       Impact factor: 4.797

6.  Molecular testing of 163 patients with Morquio A (Mucopolysaccharidosis IVA) identifies 39 novel GALNS mutations.

Authors:  A Morrone; K L Tylee; M Al-Sayed; A C Brusius-Facchin; A Caciotti; H J Church; M J Coll; K Davidson; M J Fietz; L Gort; M Hegde; F Kubaski; L Lacerda; F Laranjeira; S Leistner-Segal; S Mooney; S Pajares; L Pollard; I Ribeiro; R Y Wang; N Miller
Journal:  Mol Genet Metab       Date:  2014-03-20       Impact factor: 4.797

7.  Reduced elastogenesis: a clue to the arteriosclerosis and emphysematous changes in Schimke immuno-osseous dysplasia?

Authors:  Marie Morimoto; Zhongxin Yu; Peter Stenzel; J Marietta Clewing; Behzad Najafian; Christy Mayfield; Glenda Hendson; Justin G Weinkauf; Andrew K Gormley; David M Parham; Umakumaran Ponniah; Jean-Luc André; Yumi Asakura; Mitra Basiratnia; Radovan Bogdanović; Arend Bokenkamp; Dominique Bonneau; Anna Buck; Joel Charrow; Pierre Cochat; Isabel Cordeiro; Georges Deschenes; M Semin Fenkçi; Pierre Frange; Stefan Fründ; Helen Fryssira; Encarna Guillen-Navarro; Kory Keller; Salman Kirmani; Christine Kobelka; Petra Lamfers; Elena Levtchenko; David B Lewis; Laura Massella; D Ross McLeod; David V Milford; François Nobili; Jorge M Saraiva; C Nur Semerci; Lawrence Shoemaker; Nataša Stajić; Anja Stein; Doris Taha; Dorothea Wand; Jonathan Zonana; Thomas Lücke; Cornelius F Boerkoel
Journal:  Orphanet J Rare Dis       Date:  2012-09-22       Impact factor: 4.123

8.  Population analysis of the GLB1 gene in South Brazil.

Authors:  Cléia Baiotto; Fernanda Sperb; Ursula Matte; Cláudia Dornelles da Silva; Renata Sano; Janice Carneiro Coelho; Roberto Giugliani
Journal:  Genet Mol Biol       Date:  2011-03-01       Impact factor: 1.771

9.  Altered expression of β-galactosidase-1-like protein 3 (Glb1l3) in the retinal pigment epithelium (RPE)-specific 65-kDa protein knock-out mouse model of Leber's congenital amaurosis.

Authors:  Joane Le Carré; Daniel F Schorderet; Sandra Cottet
Journal:  Mol Vis       Date:  2011-05-07       Impact factor: 2.367

10.  SR proteins and the nonsense-mediated decay mechanism are involved in human GLB1 gene alternative splicing.

Authors:  Raül Santamaria; Lluïsa Vilageliu; Daniel Grinberg
Journal:  BMC Res Notes       Date:  2008-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.